Verbatim response from Perplexity
Usually yes, if you can get Zepbound at a reasonable out-of-pocket price or through insurance. The brand is FDA-approved and manufactured under standard commercial quality controls, while compounded tirzepatide is not FDA-approved and its use/pricing has become more complicated as the tirzepatide shortage ended and supply tightened.[14][6]
The main tradeoff is cost vs. certainty:
- Zepbound: cash prices are often around $1,060–$1,086/month at retail, but Lilly’s cash-vial programs bring some doses down to roughly $299–$549/month, and insurance/savings cards can lower costs to as little as $0–$25/month for eligible patients.[1][2][10][14]
- Compounded tirzepatide: commonly runs about $150–$599/month depending on dose and provider, so it is often cheaper when you are paying entirely out of pocket.[1][6][10][14]
Where Zepbound is worth the extra cost:
- You have insurance coverage or savings-card eligibility, making the price gap small or even reversed.[2][10][14]
- You want the FDA-approved product with the most straightforward supply and labeling.[14]
- You want to avoid the regulatory and consistency issues that can come with compounding, especially now that the shortage has ended.[6][14]
Where compounded tirzepatide may be the better buy:
- You are paying cash and Zepbound is still near retail pricing.
- You need the lowest monthly cost and understand the tradeoffs in regulatory status and pharmacy sourcing.[1][6][10][14]
A practical rule of thumb: if Zepbound costs you close to compounded tirzepatide after insurance, coupons, or LillyDirect pricing, the brand is usually the better value; if Zepbound is still several hundred dollars more per month, compounded tirzepatide can be the more budget-friendly option.[2][10][14]
If you want, I can also give you a decision rule by price bracket like “under $100,” “$100–$300,” “$300–$500,” and “over $500” per month.